Mass spectrometry-based expression profiling of clinical prostate cancer.
about
Dynamic profiling of the post-translational modifications and interaction partners of epidermal growth factor receptor signaling after stimulation by epidermal growth factor using Extended Range Proteomic Analysis (ERPA)Identification of mammalian cell lines using MALDI-TOF and LC-ESI-MS/MS mass spectrometry.Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers.Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum.Profiling of protein interaction networks of protein complexes using affinity purification and quantitative mass spectrometry.Correlation of surface-enhanced Raman spectroscopy and laser desorption-ionization mass spectrometry acquired from silver nanoparticle substrates.MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases.Clinical proteomics: present and future prospects.Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applicationsMolecular biomarkers for cancer detection in blood and bodily fluids.Potential Urinary Protein Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients.Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer.Metabolic markers of hypoxia: systems biology application in biomedicine.Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for protein markers with potential clinical utility.Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer therapy.Why have so few proteomic biomarkers "survived" validation? (Sample size and independent validation considerations).Tissue-based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma.Magnetohydrodynamic and Slip Effects on the Flow and Mass Transfer over a Microcantilever-Based Sensor
P2860
Q24294659-AC5D2EAF-6CE7-4AF9-8DEF-4F756DF1789AQ33234314-57C1091B-17CA-4897-9792-BAD9574E2A59Q33246070-EF1B3167-E9D6-4EF6-9C52-9935B9C6E84EQ33259972-F3D24713-AF91-48EB-BCAE-24A0556788BEQ34121939-3AC95776-774D-4BEE-9C40-AF511EE5B0A7Q34153236-BFD50442-3E15-4235-84A1-B221486B5F73Q35014089-EA990BD2-DE12-442D-8203-9AE7DF098EB5Q35053674-EACCB0DA-4E42-4424-A76A-4AAFFE585D26Q35610017-64460931-5A06-4AD1-AEDE-58D5738BF40CQ36627755-C5FD9665-4912-4D19-9923-E292CB4E7F23Q37540974-04021463-8429-4B7A-96DE-E185D74B0079Q37613206-DB8C9273-11A0-46CA-A566-565553D97B1AQ37658685-EAECF159-802F-4715-8B92-8F718F75D958Q37790704-FC2CEE04-5FB1-4E3C-A6BF-F76D5A9A9A3AQ38132914-528B33F8-5D4E-40DA-8858-1FD3437B0D96Q39048636-BEF32FB5-C46B-432C-91CA-65F9CF77FEEAQ45777404-2A10E024-CDAD-4185-B006-4106A0EFD205Q55295932-56A08B7E-2934-4335-9C28-A0BC1E413CA1Q58206627-2B899C3C-33FE-4710-B843-91C15EB93E01
P2860
Mass spectrometry-based expression profiling of clinical prostate cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mass spectrometry-based expression profiling of clinical prostate cancer.
@ast
Mass spectrometry-based expression profiling of clinical prostate cancer.
@en
type
label
Mass spectrometry-based expression profiling of clinical prostate cancer.
@ast
Mass spectrometry-based expression profiling of clinical prostate cancer.
@en
prefLabel
Mass spectrometry-based expression profiling of clinical prostate cancer.
@ast
Mass spectrometry-based expression profiling of clinical prostate cancer.
@en
P2860
P1476
Mass spectrometry-based expression profiling of clinical prostate cancer.
@en
P2093
David K Han
Michael E Wright
P2860
P304
P356
10.1074/MCP.R500008-MCP200
P577
2005-02-02T00:00:00Z